Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gremlin-1 antagonist for the prevention and treatment of cancer

Gremlin-1 antagonist for the prevention and treatment of cancer

US Patent 12162934 · Granted Dec 10, 2024

Estimated economic value: $25,813,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gremlin-1 crystal structure and inhibitory antibody2025
Isolation of adult multipotential cells by tissue non-specific alkaline phosphat2025
Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect2025
Gremlin-1 crystal structure and inhibitory antibody2023
Therapeutic binding molecules2023
Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect2022
Gremlin-1 antibody2021
Method of increasing proliferation of bone marrow mononuclear cells expressing S2020
Perivascular mesenchymal precursor cells2019
Monoclonal antibody STRO-42017
Isolation of adult multipotential cells by tissue non-specific alkaline phosphat2017
Perivascular mesenchymal precursor cell induced blood vessel formation2015